Biomerics Announces Merger with Precision Concepts Medical

Posted on

Biomerics (“Biomerics” or the “Company”), the leading vertically integrated contract manufacturer for the interventional medical device market, announced today that it has entered into definitive agreements to merge with Precision Concepts’ Medical business (“Precision Concepts Medical”). The transaction includes the acquisition of the medical business of Precision Concepts International (“PCI”) as well as Precision Concepts […]

Read More

Sera Prognostics Announces Retirement of President and CEO Dr. Greg Critchfield and Appointment of Board Member Zhenya Lindgardt as Interim CEO

Posted on

SALT LAKE CITY, May 15, 2023 /PRNewswire/ — Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced the retirement of the Company’s President and CEO, Gregory C. Critchfield, M.D., M.S. Dr. Critchfield is retiring after 12 years […]

Read More

Recursion Appoints David Mauro, M.D., Ph.D., as Chief Medical Officer

Posted on

SALT LAKE CITY, May 16, 2023 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has appointed David Mauro, M.D., Ph.D, as its Chief Medical Officer. Dr. Mauro will lead Recursion’s pipeline into and through clinical development, including its five programs currently in […]

Read More

Nusano and PharmaLogic Announce Collaboration to Enable Next Generation Radiotherapeutics Development

Posted on

SALT LAKE CITY and BOCA RATON, Fla. – May 15, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, and PharmaLogic, a world-class contract development and manufacturing organization (CDMO) specializing in radiopharmaceuticals, today announced the two organizations will collaborate to advance the development of radiopharmaceuticals for diagnostic and therapeutic applications.   “PharmaLogic […]

Read More

EY Announces Marcus Gerhardt and Florian Solzbacher of Blackrock Neurotech as Entrepreneur Of The Year® 2023 Mountain West Award Finalists

Posted on

SALT LAKE CITY, May 8, 2023 – Ernst & Young LLP (EY US) today announced that Marcus Gerhardt, co-founder and CEO, and Florian Solzbacher, co-founder and President, of Blackrock Neurotech were named Entrepreneur Of The Year® 2023 Mountain West Award finalists. Now in its 37th year, Entrepreneur Of The Year is one of the preeminent […]

Read More

NUSANO ANNOUNCES IN-HOUSE STABLE ISOTOPE PROGRAM LED BY RENOWNED PHYSICIST SARKO CHEREKDJIAN

Posted on

VALENCIA, Calif. and WEST VALLEY CITY, Utah – May 11, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced it is creating an in-house stable isotope program to enhance the company’s medical radioisotope production capabilities and decrease dependence on foreign supply chains. “Enriched, stable isotopes are foundational material for manufacturing […]

Read More

Foldax, Inc. Receives Full Ownership Rights to Proprietary Polymer Patent Portfolio

Posted on

SALT LAKE CITY–(BUSINESS WIRE)–Foldax® Inc. today announced that it has executed an agreement with Australia’s national science agency, CSIRO, for full ownership of a polymer technology patent family. Foldax has incorporated the polymer technology into its LifePolymer™ materials platform and has conducted testing, which indicates the materials are compatible with blood, with low adherence of […]

Read More

Bruce Hunter named new Interim Chief Innovation and Economic Engagement Officer

Posted on

By Xoel Cardenas, Sr. Communications Specialist, Office of the Vice President for Research The Partners for Innovation, Ventures, Outreach & Technology (PIVOT) Center at the University of Utah has named Bruce Hunter as the Interim Chief Innovation and Economic Engagement Officer. Hunter succeeds the role from Dr. Keith Marmer, who served as a leader for the university’s […]

Read More

Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities

Posted on

SALT LAKE CITY and TORONTO and MONTRÉAL, May 08, 2023 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has signed agreements to acquire two companies in the AI-enabled drug discovery space: Cyclica and Valence. “Recursion has pioneered the massive, parallel generation of […]

Read More